US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the US Food and Drug Administration ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

North Carolina, USA-based biotech BioCryst Pharmaceuticals on Friday announced it has signed a definitive agreement to sell ...

Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

German biosimilars company Formycon has announced that its 2025/2029 corporate bond was significantly oversubscribed due to ...

German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...